BMJ Elective Case Log

This case was being discussed in our group where the efficacy of teneligliptin was put under severe scrutiny and that triggered some academic searching activity among different conversational agents in the WhatsApp group:  AS:  Teneligliptin 20mg + Metformin SR 500 mg Combination is the choice of drug in what particular condition of DM?? RB:  Teneligliptin is often palmed off by pharma companies to unsuspecting doctors as an oral hypoglycemic with a lower chance of hypoglycemia and even advocated in diabetics with renal failure but they hide the fact that the overall efficacy of teneligliptin is less in controlling blood sugars (as it hardly reduces blood sugars) and instead of throwing it away they are marketing it as a safe drug that doesn't cause hypoglycemia. AS:  This exactly answers precisely what I wanted to know. Thank you, Sir 🤗 As I too had a suspicion regarding its efficacy out of a personal experience with one patient (family member) who was on ...

The following medical documentation is a continuation of the online patient record available here  http://keerthiereddy.blogspot.com/2019/05/fever-with-lymphadenopathy-in-male.html?m=1

What follows below is an original version of the WhatsApp conversational review that began with an invitation statement from the teacher and each participant critically appraised and reviewed the case report. As the discussion progressed, dialogue between the moderator and students centred around study, and a review report was summarized (the moderator is indicated by the title “teacher” and/or initials (R.B.) and student reviewers are indicated by their initials). AKG:  Please introduce each other. we will share a manuscript for reviewing here soon. One important guideline to follow is, you must not share the paper to be reviewed anywhere. Please follow this as its important. The manuscript is shared above. After review completes, we will blog whole conversational review. If you don't know how to do it, read paper, give your comments, ask questions, freely use google youtube and anything and also share if any useful relevant links. RB:  Here's a guideline...

The following rejected correspondence was written in respond to the editorial published in the Lancet Public Health .  Title:  Workplace health promotion in India Vivek Podder; Tetsuya Tanimoto The Lancet editorial (November 18, p 508)1 highlighted high-quality public health research for effective, low-cost interventions for workplace-related health. However, it may not work for people with poor health literacy and low socioeconomic conditions, especially in non-western countries.  For example, as a middle-income nation, India is passing through a rapid economic growth, but health promotion is often neglected at workplace. As per a report from Indian study, over 55% of private employees in India do not perform any exercise and 68% of women are afflicted with different occupational lifestyle diseases.2 In India, increasing number of chronic diseases, which the World Health Organization has attributed to physical inactivity as a key risk factor, can bring e...

The following rejected correspondence was written in respond to the editorial published in the Lancet .  Title: Reducing Meat Consumption by Intensifying Public Awareness  Vivek Podder; Md. Ferdous Rahman The Lancet editorial (November 24, p 508)1 highlighted impact of increasing meat consumption on ecological sustainability and consumers’ health. The growing demand of meat from increasing population and consequent increase in their production can be mitigated by taxing red and processed meat, reducing their consumption. We would like to specify one missing aspect to this debate.  Missing from this debate, however, is the public awareness of the health and environmental impact of meat and attitudes to reduce their consumption as studied by Clonan and their colleagues. [2] Public perception of meat as healthy food could limit their meat consumption as reflected in the UK dietary guidelines stating, “meat is a good source of protein in your diet, as well...